The native just-in-time compiler in Python 3.15 can speed up code by as much as 20% or more, although it’s still experimental ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

New research exposes how just a few hundred malicious documents can plant backdoors in AI models and distort product comparisons. In a world ruled by algorithms, SEJ brings timely, relevant ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Can all cancers become treatable and metastatic disease be halted in its tracks? Many companies share the goal of ensuring that new therapeutics address early cancers, recalcitrant protein targets, ...

After LLMs and agents, the next AI frontier: video language models The next step in the evolution of generative AI technology will rely on ‘world models’ to improve physical outcomes in the real world ...